ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Shilpa Medicare appointed Dr. Uday N. Harle as CEO of its wholly owned subsidiary, Shilpa Biologicals Private Limited. The appointment is effective from August 3, 2026.
Dr. Sridevi Khambhampaty resigned as CEO of Shilpa Biologicals Private Limited, effective 15 July 2026. The resignation from the material subsidiary is due to personal commitments.